Israel Englander’s Clover Health Investments CLOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-400,000
Closed -$856K 7105
2022
Q2
$856K Buy
400,000
+100,000
+33% +$266K ﹤0.01% 4515
2022
Q1
$1.06M Buy
300,000
+50,000
+20% +$145K ﹤0.01% 4458
2021
Q4
$930K Buy
250,000
+50,000
+25% +$307K ﹤0.01% 4476
2021
Q3
$1.48M Buy
+200,000
New +$1.71M ﹤0.01% 4255
2021
Q2
Sell
-44,600
Closed -$337K 6576
2021
Q1
$337K Sell
44,600
-420,400
-90% -$4.74M ﹤0.01% 5135
2020
Q4
$7.8M Buy
+465,000
New +$5.18M 0.01% 2019

Other funds holding CLOV

Israel Englander's CLOV Position: Q2 2026 in Review

Israel Englander reduced its Clover Health Investments (CLOV) stake by 4.8% in Q2 2026, selling an estimated $191K and leaving 1,108,721 shares worth $5.81M. The position accounts for ﹤0.01% of the portfolio, ranked #2843.

Israel Englander first reported a position in CLOV in Q2 2020 and has held it in 22 quarters since. The position peaked at $27.9M in Q2 2020. 224 funds tracked by Wall St. Rank hold CLOV as of Q2 2026.

  • Israel Englander held 1,108,721 shares of Clover Health Investments worth $5.81M as of Q2 2026.
  • Israel Englander sold 56,247 Clover Health Investments shares in Q2 2026, an estimated $191K.
  • Clover Health Investments made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #2843 holding.
  • Israel Englander first reported a position in Clover Health Investments in Q2 2020 and has held it in 22 quarters since.
  • Israel Englander's Clover Health Investments position peaked at $27.9M in Q2 2020.
  • 224 funds tracked by Wall St. Rank held Clover Health Investments as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.